1. Home
  2. RGEN vs CFR Comparison

RGEN vs CFR Comparison

Compare RGEN & CFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • CFR
  • Stock Information
  • Founded
  • RGEN 1981
  • CFR 1868
  • Country
  • RGEN United States
  • CFR United States
  • Employees
  • RGEN N/A
  • CFR N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • CFR Major Banks
  • Sector
  • RGEN Health Care
  • CFR Finance
  • Exchange
  • RGEN Nasdaq
  • CFR Nasdaq
  • Market Cap
  • RGEN 8.0B
  • CFR 7.9B
  • IPO Year
  • RGEN N/A
  • CFR N/A
  • Fundamental
  • Price
  • RGEN $123.26
  • CFR $130.46
  • Analyst Decision
  • RGEN Buy
  • CFR Hold
  • Analyst Count
  • RGEN 12
  • CFR 15
  • Target Price
  • RGEN $172.67
  • CFR $133.13
  • AVG Volume (30 Days)
  • RGEN 793.9K
  • CFR 393.5K
  • Earning Date
  • RGEN 04-29-2025
  • CFR 05-01-2025
  • Dividend Yield
  • RGEN N/A
  • CFR 3.07%
  • EPS Growth
  • RGEN N/A
  • CFR 7.71
  • EPS
  • RGEN N/A
  • CFR 9.11
  • Revenue
  • RGEN $650,429,000.00
  • CFR $2,038,108,000.00
  • Revenue This Year
  • RGEN $13.93
  • CFR $11.62
  • Revenue Next Year
  • RGEN $14.35
  • CFR $3.90
  • P/E Ratio
  • RGEN N/A
  • CFR $14.31
  • Revenue Growth
  • RGEN 4.88
  • CFR 5.45
  • 52 Week Low
  • RGEN $102.97
  • CFR $94.09
  • 52 Week High
  • RGEN $182.52
  • CFR $147.64
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 41.34
  • CFR 67.63
  • Support Level
  • RGEN $123.10
  • CFR $129.05
  • Resistance Level
  • RGEN $135.47
  • CFR $131.82
  • Average True Range (ATR)
  • RGEN 7.10
  • CFR 2.52
  • MACD
  • RGEN -1.05
  • CFR 1.52
  • Stochastic Oscillator
  • RGEN 5.39
  • CFR 92.24

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About CFR Cullen/Frost Bankers Inc.

Cullen/Frost is a regional US bank with around $50 billion in assets (as of 2024 year-end), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.

Share on Social Networks: